Latest TroVax Stories
LONDON, June 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Retrospective Study of Roswell Park Patients Documents Safety and Benefit of Complex Immunotherapy Buffalo, NY (PRWEB) May 06, 2014 A retrospective study
LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Third Phase 3 Trial of Custirsen to Receive FDA Fast Track Designation BOTHELL, Wash.
ThermoDox Demonstrates Impressive Response Rate in Refractory Patients LAWRENCEVILLE, N.J., Feb.
WORCESTER, Mass. and TORONTO, Feb.
AUSTIN, Texas, Jan.
Latest Data from Large Subgroup of Patients Shows that the Combination of ThermoDox® and Optimized RFA Provides a Statistically Significant Survival Improvement of Over 50% LAWRENCEVILLE,